CONCLUSION OF EXPERTS. NEW POSSIBILITIES OF ETIOTROPIC THERAPY OF CORONAVIRUS INFECTION.

Chulanov, V. P.; Pushkar, D. Yu, Balykova, L. A.; Gorelov, A. V.; Lioznov, D. A.; Dmitriev, A. S.; Kolontarev, K. B.; Malyavin, A. G.; Budnevsky, A. V.; Esaulenko, E. V.; Petrov, V. A.; Taganov, A. V.; Pshenichnaya, N. Yu, Omarova, K. G.

Chulanov, V. P.; Pushkar, D. Yu, Balykova, L. A.; Gorelov, A. V.; Lioznov, D. A.; Dmitriev, A. S.; Kolontarev, K. B.; Malyavin, A. G.; Budnevsky, A. V.; Esaulenko, E. V.; Petrov, V. A.; Taganov, A. V.; Pshenichnaya, N. Yu, Omarova, K. G..

Infektsionnye Bolezni ; 20(2):120-122, 2022.

Article in Russian | EMBASE | ID: covidwho-2067475

ABSTRACT

ABSTRACT

In conclusion, topical aspects of the etiotropic therapy of a new coronavirus infection and the prospects for the use of SKYVIRA 1 , which is a Russian-made combined drug in the form of tablets based on INN nirmatrelvir + ritonavir, are presented. Target. Determination of the place of medicines based on the INN nirmatrelvir + ritonavir in the etiotropic therapy of patients with a new coronavirus infection, depending on the severity of the course and the timing of the visit to the doctor. Determination of the paradigm for further studies of drugs based on nirmatrelvir. Copyright © 2022, Dynasty Publishing House. All rights reserved.

Keywords

adult; article; Coronavirus infection; drug combination; drug therapy; human; topical drug administration; nirmatrelvir; ritonavir

Fulltext

XML

Search on Google

Full text: Available Collection: Databases of international organizations Database: EMBASE Language: Russian Journal: Infektsionnye Bolezni Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google